| Exosomes derived from M. Bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo PK Giri, JS Schorey PloS one 3 (6), e2461, 2008 | 292 | 2008 |
| Proteomic analysis identifies highly antigenic proteins in exosomes from M. tuberculosis‐infected and culture filtrate protein‐treated macrophages PK Giri, NA Kruh, KM Dobos, JS Schorey Proteomics 10 (17), 3190-3202, 2010 | 205 | 2010 |
| Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis PK Giri, SB Sable, I Verma, GK Khuller FEMS Immunology & Medical Microbiology 45 (1), 87-93, 2005 | 62 | 2005 |
| Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge … PK Giri, I Verma, GK Khuller FEMS Immunology & Medical Microbiology 47 (2), 233-241, 2006 | 61 | 2006 |
| Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice PK Giri, I Verma, GK Khuller Journal of Infection 53 (5), 350-356, 2006 | 57 | 2006 |
| Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells HJ Choi, Y Geng, H Cho, S Li, PK Giri, K Felio, CR Wang Blood, The Journal of the American Society of Hematology 117 (6), 1880-1887, 2011 | 55 | 2011 |
| Role of the hepcidin-ferroportin axis in pathogen-mediated intracellular iron sequestration in human phagocytic cells R Abreu, F Quinn, PK Giri Blood advances 2 (10), 1089-1100, 2018 | 54 | 2018 |
| Is intranasal vaccination a feasible solution for tuberculosis? PK Giri, GK Khuller Expert review of vaccines 7 (9), 1341-1356, 2008 | 44 | 2008 |
| Heparin inhibits intracellular Mycobacterium tuberculosis bacterial replication by reducing iron levels in human macrophages R Abreu, L Essler, A Loy, F Quinn, P Giri Scientific Reports 8 (1), 7296, 2018 | 37 | 2018 |
| Host-pathogen interaction as a novel target for host-directed therapies in tuberculosis R Abreu, P Giri, F Quinn Frontiers in immunology 11, 513363, 2020 | 33 | 2020 |
| Interferon-gamma promotes iron export in human macrophages to limit intracellular bacterial replication R Abreu, L Essler, P Giri, F Quinn PLoS One 15 (12), e0240949, 2020 | 29 | 2020 |
| Adjunct immunotherapy with Ag85 complex proteins based subunit vaccine in a murine model of Mycobacterium tuberculosis infection PK Giri, I Verma, GK Khuller Future Medicine Ltd 1 (1), 31-37, 2009 | 9 | 2009 |
| How could we have better vaccines against tuberculosis? PK Giri Expert Opinion on Biological Therapy 8 (11), 1759-1772, 2008 | 3 | 2008 |
| New players in immune regulation PK Giri, A Sharma, DM Estes Immunotherapy 3 (11), 1290-1291, 2011 | 2 | 2011 |
| Highlights from the latest articles in immunomodulation (vol 3, pg 1289, 2011) PK Giri, A Sharma, DM Estes IMMUNOTHERAPY 4 (1), 124-124, 2012 | | 2012 |
| Is A20 a suitable target to enhance dendritic cell antigen presentation? PK Giri, A Sharma, DM Estes Journal of Medical Microbiology 58, 554-562, 2009 | | 2009 |
| miRNA-29:[corrected] a governor of IFN‑gamma production by T cells. PK Giri, A Sharma, DM Estes Journal of Medical Microbiology 58, 554-562, 2009 | | 2009 |
| Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine... PK Giri, I Verma, G Khuller | | 2006 |
| Huszar M Hwang ST Itzhaki O W Aberer, MA Ainsworth, D Amsen, RS Bass, R Bonecchi, D Bresson, ... | | |
